<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="129565">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02075476</url>
  </required_header>
  <id_info>
    <org_study_id>FRALUX-34</org_study_id>
    <nct_id>NCT02075476</nct_id>
  </id_info>
  <brief_title>the Effectiveness Between Two Surgical Techniques for Reconstruction of Humeral Proximal Extremity Fractures or Fractures Luxation in Three or Four Fragments</brief_title>
  <official_title>Prospective, Randomized and Double Blind Study of Parallels Groups for Evaluating the Effectiveness Between Two Surgical Techniques for Reconstruction of Humeral Proximal Extremity Fractures or Fractures Luxation in Three or Four Fragments of Neer's Classification.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carlos Alvarez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Universitario Gregorio Marañon</source>
  <oversight_info>
    <authority>Spain: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness and safety of two surgical
      techniques for the treatments of proximal extremity humeral fractures and fractures luxation
      in three o four fragments of Neer's  classification.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proximal extremity humeral fractures present high prevalence. It's estimated about 10% of
      all fractures. Their incidence is 6,6/1000 people-year and this amount increases from 40
      years old. The majority are successfully treated with immobilization  and rehabilitation.
      The surgical treatment is recommended in case of displacement. In elderly population with
      fractures types three or four of Neer's classification  there is no consensus on which
      technique is the best surgical option. Classically hemiarthroplasty has been widely
      performed as a reconstruction method but its outcomes in old patients are unclear due to the
      bad bone quality and joint features. Recently some authors recommend the reverse
      arthroplasty in patients over 70 years old . The aim of this study is to compare the results
      between Hemiarthroplasty and reverse arthroplasty in patients over 70 years old. As far as
      the investigators are concerned there's no published studies like this.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Effectiveness will be measured  for AMERICAN SHOULDER AND ELBOW ASES Score</measure>
    <time_frame>0, 1, 3, 6, 12, 18 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>changes en ASES score will be measured</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>surgery (in) complications</measure>
    <time_frame>0, 1, 3, 6, 12, 18 and 24 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>surgery (in) complications: bleeding, Neurovascular injuries, glenoid or humeral periprosthetic fractures)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgery (post) complications</measure>
    <time_frame>0, 1,3,6,12,18 and 24 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Surgery (post) complications:o	infection, instability, Bleeding (transfusion requirement during hospital admission)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical Time</measure>
    <time_frame>0, 1, 3, 6, 12, 18 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery time: time the patient takes for reaching maximum punctuation in ASES Score</measure>
    <time_frame>1, 3, 6, 12, 18 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>time the patient takes for reaching maximum punctuation in ASES Score</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>A02.835.232.087.090.400.400</condition>
  <arm_group>
    <arm_group_label>Hemiarthroplasty Global Fx(DePuy)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in this technique the prosthesis is implanted in similar approach to shoulder anatomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>reverse  arthroplasty Delta Xtent(DePuy)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In this technique the prosthesis is implanted in the inverse mode of shoulder anatomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hemiarthroplasty</intervention_name>
    <arm_group_label>Hemiarthroplasty Global Fx(DePuy)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>reverse arthroplasty</intervention_name>
    <arm_group_label>reverse  arthroplasty Delta Xtent(DePuy)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with humeral proximal extremity fracture or fracture luxation in three or
             four fragments of Neer's classification.

          -  Patient 70 years older

          -  Signed informed consent.

        Exclusion Criteria:

          -  Any condition to make worse the functional recovery or avoid the patient
             collaboration with the rehabilitation program ( cognitive disability, neurological
             pathology…)

               -  Glenohumeral osteoarthritis

               -  Inflammatory arthropathies

               -  Previous cuff arthropatyy

               -  High surgical  or anesthesia risk

               -  Any disease or condition that the investigator finds decisive for exclusion.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Alvarez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitario Gregorio Marañon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos Alvarez, MD</last_name>
    <phone>34914269801</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fausto Mombiela, MD</last_name>
    <phone>34914269801</phone>
    <email>mombiela@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañon</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos Alvarez, MD</last_name>
      <phone>34914269801</phone>
      <email>calvargon@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Javier Vaquero, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Miguel Lopez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Rodríguez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fausto Lopez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 4, 2014</lastchanged_date>
  <firstreceived_date>February 6, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Gregorio Marañon</investigator_affiliation>
    <investigator_full_name>Carlos Alvarez</investigator_full_name>
    <investigator_title>Head of Department</investigator_title>
  </responsible_party>
  <keyword>Fracture-luxation</keyword>
  <keyword>humeral proximal extremity</keyword>
  <keyword>Hemiarthroplasty</keyword>
  <keyword>reverse Arthroplasty</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dislocations</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
